GSK has secured approval in China for Trelegy Ellipta as a maintenance treatment for adults with asthma, adding to its existing indication in COPD and making it the only single inhaler triple therapy ...
Key market opportunities in the PLC sector include the shift to software-defined automation, driven by Industry 4.0 adoption and demand for modular architectures in large plants. Asia-Pacific leads ...